Satvat Ali J. (CIK 1621788) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy BBIO (3,990 shares), Buy CHRS (30,000 shares), Buy BBIO (6,589 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-06-09 | Coherus Oncology, Inc. (CHRS) | Director | Buy | 30,000 | $0 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
Source: SEC Form 4 filings · as of 2026-06-24